RNF213

RNF213
Identifiers
Aliases	RNF213 , ALO17, C17orf27, KIAA1618, MYMY2, MYSTR, NET57, ring finger protein 213
External IDs	OMIM: 613768 MGI: 1289196 HomoloGene: 45439 GeneCards: RNF213
Gene location (Human) Chr. Chromosome 17 (human) [1] Band 17q25.3 Start 80,260,852 bp [1] End 80,398,794 bp [1]
Gene location (Mouse) Chr. Chromosome 11 (mouse) [2] Band 11 E2|11 83.48 cM Start 119,283,926 bp [2] End 119,378,244 bp [2]
RNA expression pattern Bgee Human Mouse (ortholog) Top expressed in pancreatic ductal cell spleen sural nerve bone marrow cells upper lobe of left lung monocyte right lobe of thyroid gland right uterine tube gastric mucosa left lobe of thyroid gland Top expressed in cervix lymph node ovary otolith organ utricle interventricular septum submandibular gland blood spleen body of femur More reference expression data BioGPS n/a
Gene ontology Molecular function protein binding metal ion binding hydrolase activity ATPase activity ubiquitin-protein transferase activity transferase activity Cellular component nucleolus membrane cytoplasm cytosol Biological process ubiquitin-dependent protein catabolic process negative regulation of non-canonical Wnt signaling pathway angiogenesis sprouting angiogenesis protein homooligomerization protein autoubiquitination protein ubiquitination protein polyubiquitination Sources:Amigo / QuickGO
Orthologs Species Human Mouse Entrez 57674 672511 Ensembl ENSG00000173821 ENSMUSG00000070327 UniProt Q63HN8 n/a RefSeq (mRNA) NM_001256071 NM_020914 NM_020954 NM_001040005 RefSeq (protein) NP_001243000 NP_066005 n/a Location (UCSC) Chr 17: 80.26 – 80.4 Mb Chr 11: 119.28 – 119.38 Mb PubMed search [3] [4]
Wikidata
View/Edit Human View/Edit Mouse

Ring finger protein 213 is a protein that in humans is encoded by the RNF213 gene. ^[5] RNF213 is a 591kDa cytosolic E3 ubiquitin ligase with RING finger and AAA+ ATPase domains.

Clinical relevance

Chromosome-wide linkage analysis found that moyamoya disease locus resides in chromosome 17q25. ^[6] Genome-wide linkage analysis of 15 Japanese families of autosomal dominant moyamoya disease narrowed down the locus to 17q25.3. ^[7] Direct sequencing of the region and whole-exome sequencing identified the p.Arg4810Lys mutation in RNF213 gene as a founder mutation of moyamoya disease. ^[8] A genome-wide association study also identified RNF213 as a disease causing gene for Moyamoya disease. ^[9] Comparative evolutionary genome sequencing analyses in humans and monkeys showed that the strongest evidence for acceleration along the branch leading to hominines was RNF213. ^[10] RNF213 has been shown to be associated with blood flow and oxygen consumption. ^{[11] [12] [13]} Given that oxygen and glucose consumption scales with total neuron number, RNF213 may have played a role in facilitating the evolution of larger brains in primates. ^[10]

References

1. GRCh38: Ensembl release 89: ENSG00000173821 - Ensembl, May 2017
2. GRCm38: Ensembl release 89: ENSMUSG00000070327 - Ensembl, May 2017
3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
5. "Entrez Gene: ring finger protein 213".
6. Yamauchi T, Tada M, Houkin K, Tanaka T, Nakamura Y, Kuroda S, et al. (April 2000). "Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25". Stroke. 31 (4): 930–5. doi: 10.1161/01.str.31.4.930 . PMID   10754001.
7. Mineharu Y, Liu W, Inoue K, Matsuura N, Inoue S, Takenaka K, et al. (June 2008). "Autosomal dominant moyamoya disease maps to chromosome 17q25.3". Neurology. 70 (24 Pt 2): 2357–63. doi:10.1212/01.wnl.0000291012.49986.f9. hdl: 2433/135797 . PMID   18463369. S2CID   1766812.
8. Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, Hitomi T, et al. (Jul 2011). "Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development". PLOS ONE. 6 (7): e22542. Bibcode:2011PLoSO...622542L. doi: 10.1371/journal.pone.0022542 . PMC   3140517 . PMID   21799892.
9. Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, Kikuchi A, et al. (January 2011). "A genome-wide association study identifies RNF213 as the first Moyamoya disease gene". Journal of Human Genetics. 56 (1): 34–40. doi: 10.1038/jhg.2010.132 . PMID   21048783.
10. Scally A, Dutheil JY, Hillier LW, Jordan GE, Goodhead I, Herrero J, et al. (March 2012). "Insights into hominid evolution from the gorilla genome sequence". Nature. 483 (7388): 169–75. Bibcode:2012Natur.483..169S. doi:10.1038/nature10842. PMC   3303130 . PMID   22398555.
11. Banh RS, Iorio C, Marcotte R, Xu Y, Cojocari D, Rahman AA, et al. (July 2016). "PTP1B controls non-mitochondrial oxygen consumption by regulating RNF213 to promote tumour survival during hypoxia". Nature Cell Biology. 18 (7): 803–813. doi:10.1038/ncb3376. PMC   4936519 . PMID   27323329.
12. Kobayashi H, Kabata R, Kinoshita H, Morimoto T, Ono K, Takeda M, et al. (May 2018). "Rare variants in RNF213, a susceptibility gene for moyamoya disease, are found in patients with pulmonary hypertension and aggravate hypoxia-induced pulmonary hypertension in mice". Pulmonary Circulation. 8 (3): 2045894018778155. doi:10.1177/2045894018778155. PMC   5991195 . PMID   29718794.
13. Morimoto T, Enmi JI, Hattori Y, Iguchi S, Saito S, Harada KH, et al. (February 2018). "Dysregulation of RNF213 promotes cerebral hypoperfusion". Scientific Reports. 8 (1): 3607. Bibcode:2018NatSR...8.3607M. doi:10.1038/s41598-018-22064-8. PMC   5827518 . PMID   29483617.

Further reading

• Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, Walther TC, et al. (August 2009). "Lysine acetylation targets protein complexes and co-regulates major cellular functions". Science. 325 (5942): 834–40. Bibcode:2009Sci...325..834C. doi: 10.1126/science.1175371 . PMID   19608861. S2CID   206520776.
• Gautier VW, Gu L, O'Donoghue N, Pennington S, Sheehy N, Hall WW (May 2009). "In vitro nuclear interactome of the HIV-1 Tat protein". Retrovirology. 6: 47. doi:10.1186/1742-4690-6-47. PMC   2702331 . PMID   19454010.
• Cools J, Wlodarska I, Somers R, Mentens N, Pedeutour F, Maes B, et al. (August 2002). "Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor". Genes, Chromosomes & Cancer. 34 (4): 354–62. doi:10.1002/gcc.10033. PMID   12112524. S2CID   22808049.
• Imami K, Sugiyama N, Kyono Y, Tomita M, Ishihama Y (January 2008). "Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column". Analytical Sciences. 24 (1): 161–6. doi: 10.2116/analsci.24.161 . PMID   18187866.
• Dephoure N, Zhou C, Villén J, Beausoleil SA, Bakalarski CE, Elledge SJ, Gygi SP (August 2008). "A quantitative atlas of mitotic phosphorylation". Proceedings of the National Academy of Sciences of the United States of America. 105 (31): 10762–7. Bibcode:2008PNAS..10510762D. doi: 10.1073/pnas.0805139105 . PMC   2504835 . PMID   18669648.
• Dias Neto E, Correa RG, Verjovski-Almeida S, Briones MR, Nagai MA, da Silva W, et al. (March 2000). "Shotgun sequencing of the human transcriptome with ORF expressed sequence tags". Proceedings of the National Academy of Sciences of the United States of America. 97 (7): 3491–6. Bibcode:2000PNAS...97.3491D. doi: 10.1073/pnas.97.7.3491 . PMC   16267 . PMID   10737800.
• Han G, Ye M, Zhou H, Jiang X, Feng S, Jiang X, et al. (April 2008). "Large-scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography". Proteomics. 8 (7): 1346–61. doi: 10.1002/pmic.200700884 . PMID   18318008.